Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 33

Publication Record

Connections

Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.
Ruddy KJ, Sangaralingham LR, Van Houten H, Nowsheen S, Sandhu N, Moslehi J, Neuman H, Jemal A, Haddad TC, Blaes AH, Villarraga HR, Thompson C, Shah ND, Herrmann J
(2020) Circ Cardiovasc Qual Outcomes 13: e005984
MeSH Terms: Administrative Claims, Healthcare, Adolescent, Adult, Aged, Anthracyclines, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cancer Survivors, Data Warehousing, Echocardiography, Female, Guideline Adherence, Heart Diseases, Humans, Lymphoma, Male, Middle Aged, Practice Guidelines as Topic, Practice Patterns, Physicians', Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, United States, Young Adult
Added May 29, 2020
0 Communities
1 Members
0 Resources
27 MeSH Terms
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens.
Cadeddu Dessalvi C, Pepe A, Penna C, Gimelli A, Madonna R, Mele D, Monte I, Novo G, Nugara C, Zito C, Moslehi JJ, de Boer RA, Lyon AR, Tocchetti CG, Mercuro G
(2019) Heart Fail Rev 24: 915-925
MeSH Terms: Anthracyclines, Biomarkers, Cardiotonic Agents, Cardiotoxicity, Echocardiography, Female, Gonadal Steroid Hormones, Heart, Heart Failure, Humans, Magnetic Resonance Spectroscopy, Male, Mitochondria, Nuclear Medicine, Oxidative Stress, Prognosis, Reperfusion Injury, Risk Factors, Sex Characteristics
Added November 12, 2019
0 Communities
1 Members
0 Resources
19 MeSH Terms
Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs.
Beyer AM, Bonini MG, Moslehi J
(2019) Am J Physiol Heart Circ Physiol 317: H164-H167
MeSH Terms: Animals, Anthracyclines, Antibiotics, Antineoplastic, Cardiotoxicity, Cardiovascular System, Heart Diseases, Humans, Protective Agents
Added November 12, 2019
0 Communities
1 Members
0 Resources
8 MeSH Terms
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA
(2018) J Natl Compr Canc Netw 16: 1216-1247
MeSH Terms: Anthracyclines, Antibiotics, Antineoplastic, Antineoplastic Agents, Immunological, Bacterial Infections, Cancer Survivors, Cardiotoxicity, Humans, Immunocompromised Host, Lymphedema, Mass Screening, Medical Oncology, Neoplasms, Risk Assessment, Societies, Medical, Survivorship, United States, Vaccination, Virus Diseases
Added December 13, 2018
0 Communities
1 Members
0 Resources
18 MeSH Terms
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.
Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B, Moslehi J, Mulrooney DA, Nathan PC, Ryan TD, van der Pal HJ, van Dalen EC, Kremer LCM
(2018) J Clin Oncol 36: 2135-2144
MeSH Terms: Anthracyclines, Cancer Survivors, Cardiovascular Diseases, Child, Humans, Neoplasms
Added October 1, 2018
0 Communities
1 Members
0 Resources
6 MeSH Terms
Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults.
Wells QS, Veatch OJ, Fessel JP, Joon AY, Levinson RT, Mosley JD, Held EP, Lindsay CS, Shaffer CM, Weeke PE, Glazer AM, Bersell KR, Van Driest SL, Karnes JH, Blair MA, Lagrone LW, Su YR, Bowton EA, Feng Z, Ky B, Lenihan DJ, Fisch MJ, Denny JC, Roden DM
(2017) Pharmacogenet Genomics 27: 247-254
MeSH Terms: Adult, Anthracyclines, Cohort Studies, Demography, Female, Genome-Wide Association Study, Humans, Male, Middle Aged, Reproducibility of Results, Signal Transduction, Stroke Volume, Ventricular Function, Left
Added March 14, 2018
0 Communities
3 Members
0 Resources
13 MeSH Terms
Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.
Sethi TK, Basdag B, Bhatia N, Moslehi J, Reddy NM
(2017) Curr Hematol Malig Rep 12: 257-267
MeSH Terms: Animals, Anthracyclines, Antineoplastic Agents, Cardiotoxicity, Cardiovascular Diseases, Disease Management, Drug Evaluation, Preclinical, Hematologic Neoplasms, Humans, Molecular Targeted Therapy, Protein Kinase Inhibitors
Added March 26, 2017
0 Communities
1 Members
0 Resources
11 MeSH Terms
Cardiology patient page. Breast cancer chemotherapy and your heart.
Unitt C, Montazeri K, Tolaney S, Moslehi J
(2014) Circulation 129: e680-2
MeSH Terms: Anthracyclines, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Breast Neoplasms, Cardiomyopathies, Drug Therapy, Female, Heart Diseases, Heart Failure, Humans, Risk Factors, Trastuzumab
Added March 4, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
Emerging paradigms in cardiomyopathies associated with cancer therapies.
Ky B, Vejpongsa P, Yeh ET, Force T, Moslehi JJ
(2013) Circ Res 113: 754-64
MeSH Terms: Angiogenesis Inhibitors, Animals, Anthracyclines, Cardiomyopathies, Cardiotoxins, Humans
Added March 4, 2015
0 Communities
1 Members
0 Resources
6 MeSH Terms
Anthracyclines and heart failure.
Sawyer DB
(2013) N Engl J Med 368: 1154-6
MeSH Terms: Animals, Anthracyclines, DNA Breaks, Double-Stranded, DNA Topoisomerases, Type II, DNA-Binding Proteins, Heart Failure, Humans, Mice, Reactive Oxygen Species
Added March 5, 2014
0 Communities
1 Members
0 Resources
9 MeSH Terms